Cardiac Pacemakers, Inc.

Guidant Corporation

Caridac Pacemakers, Inc.

Yinghong Yu

Jiang Ding

Julio Cesar Spinelli

Jeffrey E Stahmann

Qi An

Pramodsingh Hirasingh Thakur

Andrew P Kramer

Krzysztof Z Siejko

Michael John Kane

Yi Zhang

Qingsheng Zhu

Aaron R McCabe

Scott A Meyer

Donald Lee Hopper

Allan Charles Shuros

Keith R Maile

David J Ternes

Sunipa Saha

Barun Maskara

David L Perschbacher

Gerrard Merrill Carlson

Joseph M Pastore

Shantha Arcot-Krishnamurthy

James O Gilkerson

Brendan Early Koop

Yanting Dong

Bruce H KenKnight

Rodney W Salo

Viktoria A Averina

Jesse W Hartley

Kent Lee

James Kalgren

Brian D Soltis

Shibaji Shome

Abhilash Patangay

Dan Li

Marina V Brockway

Stephen John Hahn

William J Linder

Quan Ni

Robert J Sweeney

Keith L Herrmann

Carlos Alberto Ricci

Jason Humphrey

Holly Elizabeth Rockweiler

Jonathan T Kwok

Milton M Morris

Adam MacEwen

Michael J Stucky

Jeng Mah

Michael James Dufresne

Bin Mi

Douglas R Daum

Benjamin J Nyquist

Joel Adam Krueger

Julie A Thompson

Alok S Sathaye

Kenneth L Baker

Arjun D Sharma

Richard Fogoros

Angelo Auricchio

Steven Lee Eddy

Martin McDaniel

Bruce Alan Tockman

Xuan K Wei

Geng Zhang

David W Yost

Lawrence S Baumann

Scott J Healy

Christopher A Hartemink

John Mark Morgan

Juan G Hincapie

Pratik K Pandya

Kenneth Matrin Stein

Michael Gold

Jagmeet Singh

Chris Hartemink

Angelo Aurichio

Jing Ding

Donald I Hopper

Michael John Stucky

Aaron R Mccabe

Kenneth M Stein

Joel A Krueger

Abihilash Patangay

Shantha Arcot-Krishnamuthy

Systems and methods for managing heart failure are described. The system receives physiological information including a first HS signal corresponding to paced ventricular contractions and a second HS signal corresponding to intrinsic ventricular contractions. The system detects worsening heart failure (WHF) using the received physiological information. A signal analyzer circuit can generate a paced HS metric from the first HS signal and a sensed HS metric from the second HS signal, and determine a concordance indicator between the paced and the sensed HS metrics. In response to the detected WHF, the system can use the concordance indicator to generate a therapy adjustment indicator for adjusting electrostimulation therapy, or a worsening cardiac contractility indicator indicating the detected WHF is attributed to degrading myocardial contractility.

Systems and methods for heart failure management

Systems and methods for monitoring and treating patients with heart failure are discussed. The system can store in a memory stimulation parameters, including stimulation timing parameters for a plurality of heart rate ranges. The system includes a plurality of timers with respective durations for the plurality of heart rate ranges. A stimulation control circuit can identify a target heart range in which a detected heart rate falls, and measure an atrioventricular (AV) conduction characteristic value in response to the timer for the target heart range being expired at the detected heart rate. The stimulation control circuit can update a stimulation parameter corresponding to the target heart rate range using the measured AV conduction characteristic. The updated stimulation parameter can be used in cardiac stimulation.

Heart rate indicated atrioventricular delay optimization

Systems and methods for monitoring and treating patients with heart failure are discussed. The system may receive patient atrioventricular (AV) conduction characteristic under different heart rates or patient conditions. Stimulation parameters including stimulation timing parameters may be stored in a memory. The system may include a stimulation control circuit configured to determine a parameter update schedule indicating a timing at which to update stimulation parameter using patient AV conduction characteristic, and dynamically update at least a portion of the stored set of stimulation parameters at the determined parameter update schedule. For a specified heart rate or heart rate range, a stimulation parameter may be selected from the set of the stimulation parameters for use during cardiac stimulation.

Dynamic atrioventricular delay optimization

Methods and systems for use of the Q-wave to R-wave interval to guide placement of a leadless cardiac pacemaker are disclosed. An implant delivery device is equipped with sensing electrodes to sense R-wave onset in a ventricle of a patient's heart to allow placement at a location of last or latest onset of the R-wave. Guidance tools are provided to assist in determination of the Q-wave to R-wave interval during implantation. For a chronic system, a cooperative approach is disclosed in which an implantable medical device and a leadless cardiac pacemaker exchange data to determine Q-wave to R-wave intervals and enhance cardiac resynchronization therapy delivery by the leadless cardiac pacemaker.

Modular cardiac rhythm management using Q to LV activation measures

Systems and methods for monitoring and treating patients with heart failure (HF) are discussed. The system may sense cardiac signals, and receives information about patient physiological or functional conditions. A stimulation parameter table that includes recommended values of atrioventricular delay (AVD) or other timing parameters maybe created at a multitude of patient physiological or functional conditions. The system may periodically reassess patient physiological or functional conditions. A therapy programmer circuit may dynamically switch between left ventricular-only pacing and biventricular pacing, or switch between single site pacing and multisite pacing based on the patient condition. The therapy programmer circuit may adjust AVD and other timing parameters using the cardiac signal input and the stored stimulation parameter table. A HF therapy may be delivered according to the determined stimulation site, stimulation mode, and the stimulation timing.

Systems and methods for dynamic control of heart failure therapy

Various aspects of the present disclosure are directed toward apparatuses, systems, and methods for pacing a HIS bundle of a patient. The apparatuses, systems, and methods may include applying stimulation energy through one or more of a plurality of electrodes to direct a stimulation locus and pace a HIS bundle of a patient.

Current steering to achieve spatial selectivity for his bundle pacing

This document discusses, among other things, systems and methods to determine a response between received cardiac electrical information from a subject, such as a time of a P wave, and received cardiac acceleration information of the subject, such as a time of a first heart sound (S1) or a second heart sound (S2), across a set of stimulation signals provided to the subject at different AVD intervals, and determining one or more cardiac resynchronization therapy (CRT) parameters using an inflection point of the determined response.

Response-based cardiac resynchronization therapy parameter determination

This document discusses, among other things, systems and methods to determine a response curve between received cardiac electrical information from a subject, such as a time of a P wave, and received cardiac acceleration information of the subject, such as a time of a first heart sound (S1) or a second heart sound (S2), to a set of stimulation signals provided to the subject at different AVD intervals. In certain examples, one or more cardiac resynchronization therapy (CRT) parameters can be determined for the subject using the determined response curve.

Cardiac resynchronization therapy heart sound response characterization

An implantable medical device (IMD) that includes a housing, a first electrode secured relative to the housing, a second electrode secured relative to the housing, and a gyroscope secured relative to the housing. The IMD may include circuitry in the housing in communication with the first electrode, the second electrode, and the gyroscope. The circuitry may be configured to determine and store a plurality of torsion data measurements, from which a representation of a twist profile may be determined.

Implantable medical device with gyroscope

Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system is disclosed. An electrical cardiac signal associated with an atrial contraction of the patient's heart and a mechanical response to the atrial contraction of a patient's heart are used to determine an atrial contraction timing fiducial. A ventricle pacing pulse may then be generated an A-V delay after the atrial contraction timing fiducial.

Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system

Growing community of inventors

Shoreview, MN, United States of America

Yinghong Yu